EuroPCR 2018: Abbott's Tendyne Mitral Valve Shows Early Promise
Executive Summary
Early data from Abbott's CE mark study of its mitral valve replacement technology Tendyne shows the device's potential in reducing mitral regurgitation in severe mitral regurgitation patients.